---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-138910"
form_type: "8-K"
ticker: null
cik: "0001923840"
company_name: "Third Harmonic Bio, Inc."
filed_at: "2024-05-15T23:59:59+00:00"
generated_at: "2026-06-01T23:41:58.969247+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# THRD reports Q1 net loss $7.9M; FDA clears THB335 IND; Phase 1 trial initiated

## Summary
- Cash $262.8M as of Mar 31, 2024; expected to fund operations through at least 2026.
- Net loss $7.9M for Q1 2024 vs $9.1M in Q1 2023; R&D expense $6.2M, G&A $5.1M.
- FDA cleared IND for THB335 (oral KIT inhibitor); Phase 1 SAD/MAD trial initiated, results expected 1H 2025.
- Leadership: Christopher Dinsmore CSO, Dennis Dean Chief Non-Clinical Dev Officer, Jennifer Dittman promoted to Chief Dev Ops Officer.

## SEC filing metadata
- accession: 0001193125-24-138910
- form_type: 8-K
- cik: 0001923840
- company_name: Third Harmonic Bio, Inc.
- filed_at: 2024-05-15T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1923840/000119312524138910/0001193125-24-138910-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1923840/000119312524138910/d840135d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-138910
- JSON: https://secwatch.observer/filing/0001193125-24-138910.json
- Plain text: https://secwatch.observer/filing/0001193125-24-138910.txt

## Key facts
- Earnings Releases
  Third Harmonic Bio, Inc. reported financial results for first quarter ended March 31, 2024.
  - Period: first quarter ended March 31, 2024
  - Result: reported results
  source text: issued a press release reporting the Company’s financial results for the first quarter ended March 31, 2024
  evidence_url: https://www.sec.gov/Archives/edgar/data/1923840/000119312524138910/0001193125-24-138910-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.